Annual Report 2011

Annual Report 2011
Download Here

Stock Exchange Announcements

Appendix 3B - Issue of Options to Directors.pdf

Change in substantial holding for Avexa

Avexa files to extend ATC patent life

Result of Annual General Meeting

All Other Announcements

Latest Company Information

Notice of Meeting 2011

Avexa's letter to Calzada dated 12 August 2010

Proxy Form AUG 2010

Avexa
  • Home
  • News
    • Press Releases 2012
    • Press Releases 2011
    • Press Releases 2010
    • Press Releases 2009
    • Press Releases 2008
    • Press Releases 2007
    • Press Releases 2006
    • Press Releases 2005
  • Corporate
    • Company Overview
    • Business Development
    • People
    • Corporate Governance
    • Avexa Employee Share Option Plan
  • Investor Relations
    • AGM
    • Company Reports
    • Prospectus 2007
    • Shareholder Newsletters
    • Analyst Reports
    • Investor Centre
  • Presentations
    • CEO's presentation to the 2009 AGM
    • Chairman's address to the 2009 AGM
    • Company Presentation April 2009
    • HIV Glasgow Conference November 2008 Apricitabine Oral Presentation
    • HIV Glasgow Conference November 2008 Apricitabine Poster
    • ICAAC Poster Washington 2008
    • AGM CEO Presentation November 2008
    • Poster XV11 HIV Drug Resistance Workshop June 2008
    • Investor Presentation March 2008
    • BIO CEO Investor Conference New York February 2008
    • CROI Poster Boston 2008
    • CEO Presentation AGM 2007
    • Investor Presentation October 2007
    • Investor Roadshow Presentation 2007
    • Investor Roadshow Presentation March 2007
    • HIV Glasgow Conference November 2006 Apricitabine Poster
    • AGM CEO presentation 2006
    • Investor Roadshow Presentation November 2006
  • FAQs
    • Avexa Demerger
    • General
    • Annual Report Information
    • Shareholder Information
  • Contact Us
    • Address and phone
    • Contact Form
Search     Site Map
Terms and Conditions |  Privacy Statement |  © 2008 Avexa Limited All Rights Reserved